ATOSSA THERAPEUTICS, INC. Public Float
ATOSSA THERAPEUTICS, INC. (ATOS) had Public Float of $107.15 million as of 2025-06-30, per its 10-K filed 2026-03-25.
Financial Statements › Notes › Cover Page
dei:EntityPublicFloat · last filed 2026-03-25
- 2025-06-30: Entity Public Float $107.15M.
- 2024-06-28: Entity Public Float $149.59M.
- 2023-06-30: Entity Public Float $159.50M.
- 2022-06-30: Entity Public Float $137.98M.
| Period end | Entity Public Float |
|---|---|
| 2025-06-30 | $107.15M 10-K · filed 2026-03-25 |
| 2024-06-28 | $149.59M 10-K · filed 2025-03-25 |
| 2023-06-30 | $159.50M 10-K · filed 2024-04-01 |
| 2022-06-30 | $137.98M 10-K · filed 2023-03-22 |
| 2021-06-30 | $795.63M 10-K · filed 2022-02-28 |
| 2020-06-30 | $35.22M 10-K · filed 2021-03-31 |
| 2019-06-30 | $23.28M 10-K · filed 2020-03-26 |
| 2018-06-30 | $4.87M 10-K · filed 2019-03-28 |
| 2017-06-30 | $4.85M 10-K · filed 2018-03-08 |
| 2016-06-30 | $9.72M 10-K/A · filed 2017-03-21 |
| 2015-06-30 | $27.42M 10-K · filed 2016-03-30 |
| 2014-06-30 | $32.86M 10-K · filed 2015-03-30 |
| 2013-06-28 | $54.13M 10-K · filed 2014-03-27 |
| 2012-06-29 | $0.00 10-K · filed 2013-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| ARTELO BIOSCIENCES, INC. (ARTL) | United States | $0.023B | |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |